Moderna has agreed to settle the dispute with Roivant for up to $2.25 billion. The claims related to the infringement of Roivant's patents by its mRNA vaccine against Covid-19. The article also mentions FDA warning letters and other pharmaceutical events. This information is part of the news overview under the name STAT+: Pharmalittle.